These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 15298047

  • 21. Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians.
    Rios DL, D'Onofrio LO, Cerqueira CC, Bonfim-Silva R, Carvalho HG, Santos-Filho A, Galvão-Castro B.
    Clin Chem Lab Med; 2007; 45(7):874-8. PubMed ID: 17617030
    [Abstract] [Full Text] [Related]

  • 22. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH, Rasmi Y, Rahimi-Pour A, Jafarzadeh M.
    Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B, Bai H, Liu R, Kumagai K, Itabe H, Takano T, Saku K.
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [Abstract] [Full Text] [Related]

  • 25. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D, Hammar N, Malmström H, Ingre C, Jungner I, Ye W, Fang F, Walldius G.
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [Abstract] [Full Text] [Related]

  • 26. Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.
    Blatter Garin MC, Moren X, James RW.
    J Lipid Res; 2006 Mar; 47(3):515-20. PubMed ID: 16327022
    [Abstract] [Full Text] [Related]

  • 27. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women.
    Wu TT, Gao Y, Zheng YY, Ma YT, Xie X.
    Lipids Health Dis; 2018 Aug 22; 17(1):197. PubMed ID: 30134981
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI, Dos Reis RP, Freitas AI, Pereira A, Sousa AC, Freitas S, Ornelas I, Freitas C, Brehm A, Araújo JJ.
    Rev Port Cardiol; 2010 Apr 22; 29(4):571-80. PubMed ID: 20734577
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M, Kiasari AM, Mokhberi V.
    Clin Chem Lab Med; 2006 Apr 22; 44(8):1015-21. PubMed ID: 16879071
    [Abstract] [Full Text] [Related]

  • 32. Differential effects of hyperhomocysteinemia on the lipid profiles and lipid ratios between patients with and without coronary artery disease: A retrospective observational study.
    Wu DF, Liao QC, Lu F, Wang Z, Yu K, Deng JL.
    Medicine (Baltimore); 2022 Dec 30; 101(52):e32464. PubMed ID: 36595992
    [Abstract] [Full Text] [Related]

  • 33. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Shen Y, Ding FH, Sun JT, Pu LJ, Zhang RY, Zhang Q, Chen QJ, Shen WF, Lu L.
    Cardiovasc Diabetol; 2015 May 13; 14():52. PubMed ID: 25964115
    [Abstract] [Full Text] [Related]

  • 34. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S, Yagi T, Atsumi W, Kawauchi K, Matsuo R, Hirayama A.
    Cardiovasc Diabetol; 2017 Oct 02; 16(1):123. PubMed ID: 28969633
    [Abstract] [Full Text] [Related]

  • 35. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
    Lee JH, Park JH, Lee SH, Kim JR, Cho KH.
    Int J Mol Med; 2010 Jun 02; 25(6):945-51. PubMed ID: 20428800
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Paraoxonase-1 (PON1) activity in patients with coronary artery diseases and in diabetic patients.
    Amine K, Atouk A, Moussamih S, Saile R, Mikou A, Kettani A.
    Ann Biol Clin (Paris); 2011 Jun 02; 69(6):671-7. PubMed ID: 22123566
    [Abstract] [Full Text] [Related]

  • 38. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
    Smuts CM, Weich HF, Weight MJ, Faber M, Kruger M, Lombard CJ, Benadé AJ.
    Coron Artery Dis; 1994 Apr 02; 5(4):331-8. PubMed ID: 8044345
    [Abstract] [Full Text] [Related]

  • 39. The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk.
    Li L, Cai G, Lu W, Li F, Yu L, Xiao J.
    BMC Cardiovasc Disord; 2021 Oct 19; 21(1):504. PubMed ID: 34666674
    [Abstract] [Full Text] [Related]

  • 40. Small Dense Low Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women: Quality or Quantity?
    Mogarekar MR, Kulkarni SK.
    Arch Med Res; 2015 Oct 19; 46(7):534-8. PubMed ID: 26348135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.